Academic Journal
Q1PharmacoEconomics
About PharmacoEconomics
PharmacoEconomics is a scholarly journal published by its listed publisher. SCImago 2025 lists it in Q1, with an SJR of 1.807 and H-index of 127.
Coverage: 1992-2026. Research categories: Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1).
Source-backed journal facts
Topics in published research
Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; Healthcare Policy and Management; Economic and Financial Impacts of Cancer; Healthcare cost, quality, practices; Economic and Environmental Valuation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,990.00 USD; 3,890.00 EUR; 3,090.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A Tutorial
Romain Jonathan Collet, Johanna Maria van Dongen, Oraluck Pattanaprateep, Suparee Wisawapipat Boonmanunt et al.
2026-09-30 · DOI: 10.1007/s40273-026-01665-6Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion
Anshul Shah, Richard Dodel, Saifuddin Kharawala, Katharina Klapper et al.
2026-09-30 · DOI: 10.1007/s40273-026-01669-2Justifying and Classifying Adults’ Roles in Child Health State Valuation: A Novel Taxonomy
Stefan A. Lipman, Vivian T. Reckers-Droog, Donna Rowen, Philip A. Powell et al.
2026-09-30 · DOI: 10.1007/s40273-026-01658-5Developing an Australian Value Set for the COCOON Carer Quality-of-Life Measure for Use in Economic Evaluations
Lidia Engel, Cathrine Mihalopoulos, Nikki McCaffrey, Thao Thai et al.
2026-09-28 · DOI: 10.1007/s40273-026-01670-9Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years
Camilla Nystrand, Naimi Johansson, Johannes Blom
2026-09-22 · DOI: 10.1007/s40273-026-01652-xBeyond Narrative and Tabular Synthesis: Introducing an Approach–Rationale–Note (ARN) Framework for Thematic Evidence Synthesis in Economic Evaluation Reviews
Mehdi Yousefi, Amy Grove, Jo Parsons, Somayeh Fazaeli et al.
2026-09-17 · DOI: 10.1007/s40273-026-01653-wEstimating the Healthcare Cost of Infection-Related Hospitalisations in Multiple Myeloma
Rainier Arnolda, Sara Carrillo de Albornoz, Laura Fanning, Adam Irving et al.
2026-09-15 · DOI: 10.1007/s40273-026-01664-7A Systematic Review of Reporting of Validation Efforts for Cancer Health Economic Decision Models
Pingping Li, Min Zhao, Yihe Tian, Hualing Yan et al.
2026-09-15 · DOI: 10.1007/s40273-026-01666-5Carbon Emission Impact of Semaglutide in People with Obesity in the UK Using a Disease Modelling Approach
Niels Lund, Christopher Lübker, Andreas Rasche, Matthew Taylor et al.
2026-09-10 · DOI: 10.1007/s40273-026-01659-4Methods for Analysing Patient-Level Utility Data: Insights from the Literature Review and Recent NICE Technology Appraisals
Saul Stevens, Maxwell S. Barnish, Alan Lovell, Frank Grimsey Jones et al.
2026-09-06 · DOI: 10.1007/s40273-026-01644-xValue of Knowing the Risk of Developing a Neurodegenerative Disease: A Discrete Choice Experiment
Patricia G. Synnott, Daniel A. Ollendorf, Steven M. Kymes, Donna L. Bernstein et al.
2026-09-06 · DOI: 10.1007/s40273-026-01655-8Landscape Analysis of Literature Using Quantitative Approaches to Synthesize Economic Evaluation Studies: A Scoping Review
Sajesh K. Veettil, Christy Thomas, Chan Jia En, Manuel Meraz et al.
2026-09-04 · DOI: 10.1007/s40273-026-01660-xDeveloping a Quality-of-Life Measure for Carers of People with Dementia for Use in Economic Evaluations: Results from the COCOON Project
Lidia Engel, Briony Dow, Anne Muldowney, Cathrine Mihalopoulos et al.
2026-09-04 · DOI: 10.1007/s40273-026-01657-6Bayesian Dynamic Borrowing to Enhance Evidence for New Therapies
Sean Yiu, Katya Galactionova, Steven Yuen, Chris Skedgel et al.
2026-09-04 · DOI: 10.1007/s40273-026-01656-7Correction: Balancing Access and Value in Multi‑Indication Medicines: Implications of PD‑(L)1 Broad Listings in Australia
Isaiah Luc, Drew Carter, Tracy Merlin
2026-10 · DOI: 10.1007/s40273-026-01654-9Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues
Jiunn Wang, Baptiste Leurent, Manuel Gomes
2026-08-12 · DOI: 10.1007/s40273-026-01651-yFail to Compare, Prepare to Fail: Comparator Omission in NICE Single Technology Appraisals
Frank Grimsey Jones, Saul Stevens, Dawn Lee
2026-08-07 · DOI: 10.1007/s40273-026-01650-zThe End of ‘Pay-and-Hope’: Managing Accelerated Approvals with Outcomes-Based Reimbursement in the Era of Routinely Collected Health Data
Giovanni Tramonti, Peter S. Hall
2026-10 · DOI: 10.1007/s40273-026-01646-9External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes
Felice Gragnano, Martin Bøg, Anders Bo Bojesen, Milana Ivkovic et al.
2026-08-03 · DOI: 10.1007/s40273-026-01649-6A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study
Lisa M. Bloudek, Allie B. Cichewicz, Kush Patel, Sean D. Sullivan et al.
2026-07-29 · DOI: 10.1007/s40273-026-01648-7Reviews
Community Reviews
Version History
September 25, 2026 at 7:13 am
September 25, 2026